Dr. Enrique Mora

Dr. Enrique Mora
Dr. Enrique Rijo completed his Urology residency in the Hospital del Mar in Barcelona (Spain) in 2011, where he worked as a Consultant Urologist and Associate Professor of Urology of the Universitat Autonoma de Barcelona (UAB) until 2015. He obtained his doctoral degree from the University of Barcelona in 2017 and received the “Best Thesis Award” from the Spanish Association of Urology (AEU). He has been working in Hospital Quiron Barcelona for the last 9 years. He is a Fellow of the European Board of Urology (FEBU) and the American College of Surgeons (FACS). Dr. Rijo is specialized in BPH surgery and has extensive experience in laser endoscopic enucleation of the prostate and other minimally invasive techniques. In the last few years he has been working as a mentor for HoLEP, GreenLEP, Rezum, i-TIND and Aquablation. He has performed many live surgeries, lectures and presented more than 200 abstracts in National and International Meetings as well as various publications.

Languages Spoken:

Spanish, English

Medical School:

Universitat Autonoma de Barcelona


Hospital del Mar. Barcelona. Spain.


Universidad Central de Vzla-2003

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only